Meanwhile, MSCs were able to excrete monocyte chemotactic protein-1 (MCP-1) to repress the activation and promote the apoptosis of CD4+ T cells via the FAS/FASL impact, thus inhibiting T lymphocyte proliferation in IBD [83, 84]. This evidence concerns the gene FASLG and inflammatory bowel disease.